Paper24809298
Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis.
Heidegger I and 4 others. Oncotarget, 2014. Cited by 67 papers, by iCite.
Cite this record
ConductScience Library. Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis. Papers, record 24809298. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24809298
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis.
- PubMed
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, CD | Major topic |
| Cell Movement | Major topic |
| Cell Proliferation | Major topic |
| Neovascularization, Pathologic | Major topic |
| Prostatic Neoplasms | Major topic |
| Receptor, IGF Type 1 | Major topic |
| Receptor, Insulin | Major topic |
| Animals | |
| Apoptosis | |
| Blotting, Western | |
| Cell Adhesion | |
| Chickens | |
| Chorioallantoic Membrane | |
| Flow Cytometry | |
| Humans | |
| Immunoenzyme Techniques | |
| Male | |
| Mice | |
| RNA, Messenger | |
| RNA, Small Interfering | |
| Real-Time Polymerase Chain Reaction | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Signal Transduction | |
| Tumor Cells, Cultured | |
| Xenograft Model Antitumor Assays |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| W 1101 | Austrian Science Fund FWF | Austria | PubMed |
Source PubMed
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21264842 | Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45. | Cancer | 2011 | https://conductscience.org/library/papers/21264842 | PubMed |
| 2 | 22903612 | Diverse functions of IGF/insulin signaling in malignant and noncancerous prostate cells: proliferation in cancer cells and differentiation in noncancerous cells. | Endocrinology | 2012 | https://conductscience.org/library/papers/22903612 | PubMed |
| 3 | 17259557 | IGF1R signalling and its inhibition. | Endocr Relat Cancer | 2006 | https://conductscience.org/library/papers/17259557 | PubMed |
| 4 | 16585177 | hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis. | Cancer Res | 2006 | https://conductscience.org/library/papers/16585177 | PubMed |
| 5 | 12138094 | Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. | J Biol Chem | 2002 | https://conductscience.org/library/papers/12138094 | PubMed |
| 6 | 22337149 | The insulin and insulin-like growth factor receptor family in neoplasia: an update. | Nat Rev Cancer | 2012 | https://conductscience.org/library/papers/22337149 | PubMed |
| 7 | 23041061 | Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205. | Am J Pathol | 2012 | https://conductscience.org/library/papers/23041061 | PubMed |
| 8 | 21311212 | Targeting the insulin-like growth factor network in cancer therapy. | Cancer Biol Ther | 2011 | https://conductscience.org/library/papers/21311212 | PubMed |
| 9 | 15641016 | Insulin-like growth factor ligands, receptors, and binding proteins in cancer. | J Pathol | 2005 | https://conductscience.org/library/papers/15641016 | PubMed |
| 10 | 23983239 | Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective study. | Cancer Epidemiol Biomarkers Prev | 2013 | https://conductscience.org/library/papers/23983239 | PubMed |
| 11 | 21983635 | Expression of the IGF axis is decreased in local prostate cancer but enhanced after benign prostate epithelial differentiation and TGF-β treatment. | Am J Pathol | 2011 | https://conductscience.org/library/papers/21983635 | PubMed |
| 12 | 19602055 | Cell and molecular mechanisms of insulin-induced angiogenesis. | J Cell Mol Med | 2009 | https://conductscience.org/library/papers/19602055 | PubMed |
| 13 | 21908557 | A kinome-wide screen identifies the insulin/IGF-I receptor pathway as a mechanism of escape from hormone dependence in breast cancer. | Cancer Res | 2011 | https://conductscience.org/library/papers/21908557 | PubMed |
| 14 | 19029956 | Insulin and insulin-like growth factor signalling in neoplasia. | Nat Rev Cancer | 2008 | https://conductscience.org/library/papers/19029956 | PubMed |
| 15 | 22530130 | Castration-resistant prostate cancer: mechanisms, targets, and treatment. | Prostate Cancer | 2012 | https://conductscience.org/library/papers/22530130 | PubMed |
| 16 | 23531874 | A kinase-independent biological activity for insulin growth factor-1 receptor (IGF-1R) : implications for inhibition of the IGF-1R signal. | Oncotarget | 2013 | https://conductscience.org/library/papers/23531874 | PubMed |
| 17 | 20924377 | Insulin-like growth factors and insulin control a multifunctional signalling network of significant importance in cancer. | Br J Cancer | 2010 | https://conductscience.org/library/papers/20924377 | PubMed |
| 18 | 19752219 | Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. | Endocr Rev | 2009 | https://conductscience.org/library/papers/19752219 | PubMed |
| 19 | 16983336 | Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis. | Oncogene | 2007 | https://conductscience.org/library/papers/16983336 | PubMed |
| 20 | 22140443 | Understanding the mechanism of insulin and insulin-like growth factor (IGF) receptor activation by IGF-II. | PLoS One | 2011 | https://conductscience.org/library/papers/22140443 | PubMed |
Cited by53
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40630212 | MiR-221, miR-320a, miR133a, and miR-133b as potential biomarkers in leiomyosarcoma. | Front Oncol | 2025 | https://conductscience.org/library/papers/40630212 | PubMed |
| 39781351 | Investigating causal relationships of blood and urine biomarkers with urological cancer risks: a mendelian randomization study and colocalization analyses. | J Cancer | 2025 | https://conductscience.org/library/papers/39781351 | PubMed |
| 39622796 | Comparative transcriptomic, epigenomic and immunological analyses identify drivers of disparity in high-grade serous ovarian cancer. | NPJ Genom Med | 2024 | https://conductscience.org/library/papers/39622796 | PubMed |
| 39439887 | Mouse liver sinusoidal endothelial cell responses to the glucocorticoid receptor agonist dexamethasone. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39439887 | PubMed |
| 39365756 | Insulin-like growth factor 1 receptor expression correlates with programmed death ligand 1 expression and poor survival in non-small cell lung cancer. | PLoS One | 2024 | https://conductscience.org/library/papers/39365756 | PubMed |
| 39247145 | Current landscape of exosomal non-coding RNAs in prostate cancer: Modulators and biomarkers. | Noncoding RNA Res | 2024 | https://conductscience.org/library/papers/39247145 | PubMed |
| 39028815 | R-loop resolution by ARIP4 helicase promotes androgen-mediated transcription induction. | Sci Adv | 2024 | https://conductscience.org/library/papers/39028815 | PubMed |
| 38874510 | Therapeutic targets of formononetin for treating prostate cancer at the single-cell level. | Aging (Albany NY) | 2024 | https://conductscience.org/library/papers/38874510 | PubMed |
| 38867724 | Insulin-related traits and prostate cancer: A Mendelian randomization study. | Comput Struct Biotechnol J | 2024 | https://conductscience.org/library/papers/38867724 | PubMed |
| 38331804 | Insulin receptor alternative splicing in breast and prostate cancer. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/38331804 | PubMed |
| 37894751 | The IGF-Independent Role of IRS-2 in the Secretion of MMP-9 Enhances the Growth of Prostate Carcinoma Cell Line PC3. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37894751 | PubMed |
| 37834454 | Insulin Receptor Isoforms and Insulin Growth Factor-like Receptors: Implications in Cell Signaling, Carcinogenesis, and Chemoresistance. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37834454 | PubMed |
| 37815978 | Automation, live-cell imaging, and endpoint cell viability for prostate cancer drug screens. | PLoS One | 2023 | https://conductscience.org/library/papers/37815978 | PubMed |
| 36755926 | Obesity and endocrine-related cancer: The important role of IGF-1. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/36755926 | PubMed |
| 36389688 | Single-cell atlas of murine adrenal glands reveals immune-adrenal crosstalk during systemic Candida albicans infection. | Front Immunol | 2022 | https://conductscience.org/library/papers/36389688 | PubMed |
| 35887136 | The Insulin Receptor: An Important Target for the Development of Novel Medicines and Pesticides. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35887136 | PubMed |
| 35454907 | Application of Proteogenomics to Urine Analysis towards the Identification of Novel Biomarkers of Prostate Cancer: An Exploratory Study. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35454907 | PubMed |
| 35241721 | Radiotherapy alters expression of molecular targets in prostate cancer in a fractionation- and time-dependent manner. | Sci Rep | 2022 | https://conductscience.org/library/papers/35241721 | PubMed |
| 35216085 | The Induced Expression of BPV E4 Gene in Equine Adult Dermal Fibroblast Cells as a Potential Model of Skin Sarcoid-like Neoplasia. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35216085 | PubMed |
| 34924998 | Antiproliferative, Antiangiogenic, and Antimetastatic Therapy Response by Mangiferin in a Syngeneic Immunocompetent Colorectal Cancer Mouse Model Involves Changes in Mitochondrial Energy Metabolism. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34924998 | PubMed |
Genes24
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24809298
GET https://conductscience.org/api/papers/v1/24809298/references?page=2